Cafepharma Today

June 13 2025 - Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
Moderna falls on doubts over new CDC panel's backing of RSV vaccine
Urogen’s bladder cancer drug wins FDA approval over adcomm’s objections
A day in the life of GSK’s U.S. president
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharmacyclics Shares Plunged: What You Need to Know
Motley Fool
Saturday, December 10, 2011 - 12:47pm
tags:
Pharmacyclics, JNJ
1 Biotech Soars While Another Crashes
Motley Fool
Saturday, December 10, 2011 - 12:45pm
tags:
Adeona, Cell Therapeutics, SIGA technologies, PharmAthene
Human Genome Upped to Neutral
Yahoo/Zacks
Saturday, December 10, 2011 - 12:42pm
tags:
Human Genome Sciences
Questcor Acthar Drug Getting Bigger Role
Yahoo/Investor's Business Daily
Saturday, December 10, 2011 - 12:42pm
tags:
Questcor Pharmaceuticals, Acthar
Spectrum Stock Tumbles 6% As Cancer Drug Threatened
Investor's Business Daily
Saturday, December 10, 2011 - 12:40pm
tags:
Spectrum, Fusilev, generics
Spectrum’s Fusilev Doesn’t Face Threat From Generics, CEO Shrotriya Says Q
Bloomberg
Saturday, December 10, 2011 - 12:38pm
tags:
Fusilev, Spectrum Pharmaceuticals, generics, colon cancer
Are Allergan's Numbers Better Than They Look?
Motley Fool
Friday, December 9, 2011 - 12:36pm
tags:
Allergan
Cell Therapeutics Shares Decline on Offering News
Forbes
Friday, December 9, 2011 - 12:04pm
tags:
Cell Therapeutics, stock offering
Gilead Reports Non-inferior Data From Phase 3 Study Of Elvitegravir In HIV
NASDAQ.com
Friday, December 9, 2011 - 12:02pm
tags:
HIV, Gilead, elvitegravir
Ex-Pfizer cancer drug shows mixed results in mid-stage studies
Fierce Biotech
Friday, December 9, 2011 - 11:59am
tags:
Pfizer, Puma Biotechnology, breast cancer, neratinib, PB272
Affymax: A Soaring Biotech With Room to Run
Motley Fool
Friday, December 9, 2011 - 11:43am
tags:
Affymax, peginesatide
1-Star Stocks Poised to Plunge: Inhibitex?
Motley Fool
Friday, December 9, 2011 - 11:31am
tags:
Inhibitex
Pfizer Wins Review of Punitive-Damages Award in Prempro Case
Bloomberg
Friday, December 9, 2011 - 11:28am
tags:
Pfizer, Prempro, Wyeth, HRT
Diabetes Meds, Pancreatitis & Prescribing Habits
Pharmalot
Friday, December 9, 2011 - 11:26am
tags:
diabetes, pancreatitis, physicians, Byetta, Amylin, Januvia, Merck
Obama supports less access to morning-after pill
Reuters
Friday, December 9, 2011 - 11:25am
tags:
Obama, Plan B contraceptive, morning-after pill
Five Biotech Stocks to Watch Going into Big Doctors' Meeting
Minyanville
Friday, December 9, 2011 - 11:11am
tags:
Seattle Genetics, ONYX Pharmaceuticals, Incyte, Celgene, Ariad Pharmaceuticals
The Worst Biotech CEO of 2011 Is ...
TheStreet.com
Friday, December 9, 2011 - 10:57am
tags:
biotech, Mitchell Gold, Dendreon
Future Dividend Growth In Bristol-Myers Squibb Will Be Weak
Seeking Alpha
Friday, December 9, 2011 - 9:41am
tags:
dividends, Bristol-Myers Squibb
FDA finds quality lapses, other serious problems in factory for unavailable J&J cancer drug
Yahoo/AP
Friday, December 9, 2011 - 9:40am
tags:
FDA, JNJ, Doxil
J&J to Pay Pharmacyclics as Much as $975 Million in Cancer Deal
Bloomberg
Friday, December 9, 2011 - 9:39am
tags:
JNJ, Pharmacyclics, PCI-32765, non-Hodgkin's lymphoma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.